The ACSS Consortium welcomes the U.K. as its newest member
Industry member
Chinese Proprietary Medicines
Health supplements
Therapeutic Products
Traditional medicines
15 October 2020
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
The heads of the Australia-Canada-Singapore-Switzerland (ACSS) Consortium are pleased to announce that the U.K. Medicines and Healthcare products Regulatory Authority (MHRA) is joining as a new member. The consortium will now be known as Access Consortium. The MHRA will officially commence working with consortium partners as a full member on 1 January, 2021, with a period of shadowing before then.
For more information on HSA's collaborations in Access Consortium, please visit the following links:
Subscribe to stay up to date with HSA news and regulatory updates.
